A citation-based method for searching scientific literature

Craig S McIntosh, May Thandar Aung-Htut, Sue Fletcher, Steve D Wilton. Int J Mol Sci 2019
Times Cited: 8







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice.
Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
55
50

Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Melvin M Evers, Hoang-Dai Tran, Ioannis Zalachoras, Barry A Pepers, Onno C Meijer, Johan T den Dunnen, Gert-Jan B van Ommen, Annemieke Aartsma-Rus, Willeke M C van Roon-Mom. Neurobiol Dis 2013
49
50

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
May T Aung-Htut, Craig S McIntosh, Kristin A Ham, Ianthe L Pitout, Loren L Flynn, Kane Greer, Sue Fletcher, Steve D Wilton. Int J Mol Sci 2019
9
50

Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in COL7A1.
Kristin A Ham, May Thandar Aung-Htut, Sue Fletcher, Steve D Wilton. Int J Mol Sci 2020
7
57

Pathogenesis of SCA3 and implications for other polyglutamine diseases.
Hayley S McLoughlin, Lauren R Moore, Henry L Paulson. Neurobiol Dis 2020
34
37

Repeat expansion diseases.
Henry Paulson. Handb Clin Neurol 2018
112
37

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries.
Abbie M Adams, Penny L Harding, Patrick L Iversen, Catherine Coleman, Sue Fletcher, Steve D Wilton. BMC Mol Biol 2007
62
37

The pathobiology of splicing.
Amanda J Ward, Thomas A Cooper. J Pathol 2010
250
37


A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.
Dunhui Li, May T Aung-Htut, Kristin A Ham, Sue Fletcher, Steve D Wilton. Int J Mol Sci 2020
4
75

Trinucleotide repeat disorders.
Harry T Orr, Huda Y Zoghbi. Annu Rev Neurosci 2007
972
25

Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.
Anna Kotowska-Zimmer, Yuliya Ostrovska, Marta Olejniczak. Mol Ther Nucleic Acids 2020
9
25


Repeat-associated RNA structure and aberrant splicing.
Melissa A Hale, Nicholas E Johnson, J Andrew Berglund. Biochim Biophys Acta Gene Regul Mech 2019
9
25

Disease Mechanisms of C9ORF72 Repeat Expansions.
Tania F Gendron, Leonard Petrucelli. Cold Spring Harb Perspect Med 2018
44
25

RNA toxicity and foci formation in microsatellite expansion diseases.
Nan Zhang, Tetsuo Ashizawa. Curr Opin Genet Dev 2017
48
25

RNA biology of disease-associated microsatellite repeat expansions.
Kushal J Rohilla, Keith T Gagnon. Acta Neuropathol Commun 2017
37
25

Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis.
Holly B Kordasiewicz, Lisa M Stanek, Edward V Wancewicz, Curt Mazur, Melissa M McAlonis, Kimberly A Pytel, Jonathan W Artates, Andreas Weiss, Seng H Cheng, Lamya S Shihabuddin,[...]. Neuron 2012
454
25


Golodirsen for Duchenne muscular dystrophy.
S Anwar, T Yokota. Drugs Today (Barc) 2020
9
25

Basic local alignment search tool.
S F Altschul, W Gish, W Miller, E W Myers, D J Lipman. J Mol Biol 1990
25

Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.
Nirmal K Singh, Natalia N Singh, Elliot J Androphy, Ravindra N Singh. Mol Cell Biol 2006
292
25

Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
Qun Pan, Ofer Shai, Leo J Lee, Brendan J Frey, Benjamin J Blencowe. Nat Genet 2008
25

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice.
Joanna A Korecka, Ria Thomas, Anthony J Hinrich, Alyssa M Moskites, Zach K Macbain, Penelope J Hallett, Ole Isacson, Michelle L Hastings. Mol Ther Nucleic Acids 2020
12
25

RNA mis-splicing in disease.
Marina M Scotti, Maurice S Swanson. Nat Rev Genet 2016
479
25

Protein misfolding in neurodegenerative diseases: implications and strategies.
Patrick Sweeney, Hyunsun Park, Marc Baumann, John Dunlop, Judith Frydman, Ron Kopito, Alexander McCampbell, Gabrielle Leblanc, Anjli Venkateswaran, Antti Nurmi,[...]. Transl Neurodegener 2017
208
25

The nuts and bolts of the endogenous spliceosome.
Ruth Sperling. Wiley Interdiscip Rev RNA 2017
25
25

Diseases of unstable repeat expansion: mechanisms and common principles.
Jennifer R Gatchel, Huda Y Zoghbi. Nat Rev Genet 2005
551
25

Alternative splicing as a regulator of development and tissue identity.
Francisco E Baralle, Jimena Giudice. Nat Rev Mol Cell Biol 2017
371
25

Function of alternative splicing.
Olga Kelemen, Paolo Convertini, Zhaiyi Zhang, Yuan Wen, Manli Shen, Marina Falaleeva, Stefan Stamm. Gene 2013
395
25

Repeat expansion disease: progress and puzzles in disease pathogenesis.
Albert R La Spada, J Paul Taylor. Nat Rev Genet 2010
288
25

In Vitro Validation of Phosphorodiamidate Morpholino Oligomers.
May T Aung-Htut, Craig S McIntosh, Kristin A West, Sue Fletcher, Steve D Wilton. Molecules 2019
8
25

Exon and intron definition in pre-mRNA splicing.
Laura De Conti, Marco Baralle, Emanuele Buratti. Wiley Interdiscip Rev RNA 2013
163
25

The chemical evolution of oligonucleotide therapies of clinical utility.
Anastasia Khvorova, Jonathan K Watts. Nat Biotechnol 2017
406
25

Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping.
Dunhui Li, Frank L Mastaglia, Sue Fletcher, Steve D Wilton. Trends Pharmacol Sci 2018
25
25


Antisense oligonucleotides in therapy for neurodegenerative disorders.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Adv Drug Deliv Rev 2015
168
25

Alternative splicing: functional diversity among voltage-gated calcium channels and behavioral consequences.
Diane Lipscombe, Arturo Andrade, Summer E Allen. Biochim Biophys Acta 2013
73
25

Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy.
Christopher J Mann, Kaite Honeyman, Graham McClorey, Sue Fletcher, Stephen D Wilton. J Gene Med 2002
116
25

Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
Lodewijk J A Toonen, Iris Schmidt, Martijn S Luijsterburg, Haico van Attikum, Willeke M C van Roon-Mom. Sci Rep 2016
24
25

Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries.
Khine Zaw, Kane Greer, May Thandar Aung-Htut, Chalermchai Mitrpant, Rakesh N Veedu, Sue Fletcher, Steve D Wilton. Front Genet 2019
3
66

Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.
May T Aung-Htut, Iain Comerford, Russell Johnsen, Kerrie Foyle, Sue Fletcher, Steve D Wilton. Sci Rep 2019
8
25

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.
Jinkuk Kim, Chunguang Hu, Christelle Moufawad El Achkar, Lauren E Black, Julie Douville, Austin Larson, Mary K Pendergast, Sara F Goldkind, Eunjung A Lee, Ashley Kuniholm,[...]. N Engl J Med 2019
179
25

Spinocerebellar ataxias: prospects and challenges for therapy development.
Tetsuo Ashizawa, Gülin Öz, Henry L Paulson. Nat Rev Neurol 2018
80
25

Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin, Lauren R Moore, Ravi Chopra, Robert Komlo, Megan McKenzie, Kate G Blumenstein, Hien Zhao, Holly B Kordasiewicz, Vikram G Shakkottai, Henry L Paulson. Ann Neurol 2018
67
25

Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Ricardo Afonso-Reis, Inês T Afonso, Clévio Nóbrega. Int J Mol Sci 2021
3
66

Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons.
I-Cheng Chen, Kuo-Hsuan Chang, Yi-Jing Chen, Yi-Chun Chen, Guey-Jen Lee-Chen, Chiung-Mei Chen. Oxid Med Cell Longev 2019
5
40

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
31
25

The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models.
Jung-Yu Hsu, Yu-Ling Jhang, Pei-Hsun Cheng, Yu-Fan Chang, Su-Han Mao, Han-In Yang, Chia-Wei Lin, Chuan-Mu Chen, Shang-Hsun Yang. Front Mol Neurosci 2017
20
25

Polyglutamine spinocerebellar ataxias - from genes to potential treatments.
Henry L Paulson, Vikram G Shakkottai, H Brent Clark, Harry T Orr. Nat Rev Neurosci 2017
136
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.